iShares MSCI Hong Kong ETF vs Novartis AG — how do they compare? iShares MSCI Hong Kong ETF trades at $22.75, while Novartis AG trades at $152.38 (market cap $295.37B). The key difference: Novartis AG pays a 3.07% dividend while iShares MSCI Hong Kong ETF pays none, and Novartis AG is trading nearer its 52-week high, iShares MSCI Hong Kong ETF nearer its low. Which is the better fit depends on your goals.
| EWH | NVS | |
|---|---|---|
Sector | Broad Market / Factor | Health |
52-Week High | $24.55 | $168.62 |
52-Week Low | $20.66 | $119.31 |
Market Cap | — | $295.37B |
Enterprise Value | — | $336.69B |
Dividend Yield | — | 3.07% |
Trailing returns across standard periods
Latest headlines on both assets
EWH tracks the MSCI Hong Kong 25/50 Index, providing broad exposure to large and mid-cap companies listed in Hong Kong. It focuses on the established pillars of the local economy, with heavy weightings in financials, real estate, and utilities, serving as a single-country diversification tool.
Read more on EWH →Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.
Read more on NVS →